![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
0
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-6-2023-36272.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-31-2023-56013.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-27-2022-1659339221.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-01-2022-1654158193.pdf
https://economictimes.indiatimes.com/industry/healthcare/biotech/biocon-gets-us-fda-nod-to-launch-insulin-glargine/articleshow/76333456.cms
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-30-2019-1572405657.pdf
https://www.pharmacompass.com/pdf/news/us-fda-enforcement-report-8june2016-1465388450.pdf
http://www.pharma-excipients.ch/2016/04/13/amino-acids-as-co-amorphous-excipients-for-tackling-the-poor-aqueous-solubility-of-valsartan/
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0301-2015&w=12242014&lang=eng